The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2445-2451

  Matkowski, Rafal ^a   Gisterek, Iwona ^a   Halon, Agnieszka ^a   Lacko, Aleksandra ^a   Szewczyk, Krzysztof ^a   Staszek, Urszula ^b   Pudelko, Marek ^b   Szynglarewicz, Bartlomiej ^b   Szelachowska, Jolanta ^a   Zolnierek, Andrzej ^c   Kornafel, Jan ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Breast cancer; CD4; CD8; Prognostic factors; Tumor infiltrating lymphocytes

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, PROGESTERONE;

EID: 69249174148     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Westermann J and Pabst R: Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today 11: 406-410, 1990.
2. Black MM: Immunopathology of breast cancer. Pathobiol Annu 7: 213-230,1977.
3. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E and Syrjanen K: Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 28A: 859-864, 1992.
4. Whitfort P, Mallon EA, George WD and Campbell AM: Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br J Cancer 62: 971-975, 1990.
5. Vgenopoulou S, Lazaris AC, Markopoulos C, Boltetsou E, Kyriakou V, Kavantzas N, Patsouris E and Davaris PS: Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise-specified type. Breast 72: 172-178,2003. (Pubitemid 36665514)
6. Foster RS Jr: The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin N Am 5: 79-104, 1996. (Pubitemid 26047384)
7. Moore KH, Thaler HT, Tan LK, Borgen PI and Coody III HS: Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma. Cancer 100: 929-934, 2004.
8. Weigelt B, Verduijn P, Bosma AJ, Rutgers EJ, Peterse HL and van't Veer LJ: Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 90: 1531-1537, 2004. (Pubitemid 38648234)
9. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A and Viale G: Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23: 1379-1389, 2005. (Pubitemid 46260025)
10. Quiet CA, Ferguson DJ, Weichselbaum RR and Hellman S: Natural history of node-negative breast cancer: a study of 826 patients with long term follow up. J Clin Oncol 13: 355-366, 1995.
11. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW and Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401, 1995.
12. Giuliano AE, Jones RC, Brennan M and Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345-2350, 1997.
13. Fisher B, Saffer E and Fisher ER: Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells. Cancer 33: 631-636, 1974.
14. Papaioannou A: The contribution of regional lymph nodes in the resistance against breast cancer: practical implications. J Surg Oncol 25: 232-239, 1984.
15. Georgiannos SN, Renauy A, Goode AW and Sheaff M: The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery 134: 827-834, 2003.
16. La Rocca G, Anzalone R, Corrao S, Magno F, Rappa F, Marasa S, Czarnecka AM, Marasa L, Sergi C, Zummo G and Cappello F: CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome. Histopathology 52: 203-212, 2008.
17. Rubbert A, Manger B, Lang N, Kalden JR and Platzer E: Functional characterization of tumor-infiltrating lymphocytes, lymph node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer. Int J Cancer 49: 25-31, 1991.
18. + T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 61: 5132-5136, 2001.
19. Macchetti AH, Marana HRC, Silva JS, de Andrade JM, Ribeiro-Silva A and Bighetti S: Tumor-infiltrating CD-4 T lymphocytes in early breast cancer reflect lymph node involvement. Clinics 61:203-208, 2006.
20. + T-cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494, 1998.
21. +/regulatory T-cell ratio are associated with favorable prognosis in ovarian cancer. PNAS 702: 18538-18543, 2005. (Pubitemid 43011261)
22. Eerola AK, Soini Y and Paakko P: A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 6: 1875-1881,2000.
23. + cells is associated with increased risk of relapse in squamous cell cervical cancer. Br J Cancer 97: 1135-1138, 2007.
24. Zhang L, Conejo-Garcia JR, Katsaros D, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC and Coukos G: Intratumoral T-cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213, 2003. (Pubitemid 36077915)
25. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW and Tang ZY: Intratumoral balance of regulatory and cytotoxic T-cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593, 2007. (Pubitemid 47041232)